United Kingdom· GB-APID-24376511000001109
Capecitabine 300mg tablets
A capecitabine product containing capecitabine, registered in United Kingdom by medac UK. The same ATC class is registered in 17 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Capecitabine is registered in 17 of 19 countries.
Countries holding a registration under ATC L01BC06 (capecitabine), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 10 of them publish a price we can compare per daily dose
Capecitabine · ATC L01BC06
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of capecitabine costs, country by country.
Normalised to the WHO defined daily dose (3 g), the median price runs from $2.73 in United States to $15.27 in Switzerland — a ×5.6 gap.
- 4 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
- US figures are pharmacy acquisition cost (CMS NADAC), not retail
Capecitabine · price per daily dose (3 g)
USD · FX 28 Sept 2026
- CH Switzerland$15.27
- IT Italy$12.14
- FR France$8.39
- US United States$2.73 (acquisition cost)
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Capecitabine
- Manufacturer
- medac UK
- Country
- United Kingdom (GB)
- ATC code
- L01BC06
- ATC class
- Capecitabine
- Defined daily dose
- 3 g, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin4037353012370
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
366 interactions on record for capecitabine.
Graded by severity as the source publishes them — 35 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Capecitabine · interactions on record
366 records
- 35 severe
- 103 moderate
- 27 minor
- 200 info
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- Folic acidB03BB01severe
- CladribineL01BB04severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Capecitabine in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCAPECITABINE ACCORDAccord Healthcare S.L.U., Barcelona
- United StatescapecitabineCamber Pharmaceuticals, Inc.
- FinlandCapecitabin ActavisActavis Group PTC ehf
- SpainCAPECITABINA ACCORD 150 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGAccord Healthcare S.L.U.
- BelgiumBinoda 500 mgAlfred E. Tiefenbacher
- NetherlandsCapecitabine Accord 150 mgAccord Healthcare S.L.U.
- SwedenCapecitabin STADA 150 mg Filmdragerad tablettSTADA Arzneimittel AG
- FranceCAPECITABINE ACCORD 150 mg, comprimé pelliculéACCORD HEALTHCARE (ESPAGNE)
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Capecel, Capecitabin Sandoz
- Bulgaria · Капецитабин Алуфарма, Капецитабин Зентива К.С
- Cyprus · Capecitabine Koanaa 150mg, Capecitabine Koanaa 500mg
- Czechia · Capecitabine, Capecitabine Pharmagen
- Germany · Capecitabin Al, Capecitabin Amarox
- Denmark · Capecitabin Stada, Capecitabin Zentiva
- Estonia · Capecitabine Zentiva, Capecitabine Zentiva K.S.
- Spain · Capecitabina Glenmark, Capecitabina Kern Pharma
- Finland · Capecitabine Orion
- France · Capecitabine Arrow, Capecitabine Biogaran
- Greece · Capecitabine Mylan, Capibine
- Croatia · Kapecitabin Jgl 500 Mg, Kapecitabin Sandoz
- Hungary · Capecitabin Onkogen, Capecitabine Pharmacenter
- Iceland · Capecitabine Accord, Capecitabine Medac
- Italy · Capecitabina Mylan, Capecitabina Zentiva
- Liechtenstein · Capecitabine Accord, Capecitabine Medac
- Lithuania · Capecitabine Zentiva, Capecitabine Zentiva K.S.
- Latvia · Capecitabine Zentiva, Capecitabine Zentiva K.S.
- Malta · Capecitabine Pharmacare, Kapetral
- Netherlands · Capecitabine Amarox, Capecitabine Cf
- Norway · Capecitabine Accord, Capecitabine Medac
- Poland · Capecitabine Glenmark
- Portugal · Capecitabina Aurovitas, Capecitabina Farmoz
- Romania · Capecitabină Dr. Reddy's, Cerex
- Sweden · Capecitabin Stada, Capecitabine Orion
- Slovenia · Kapecitabin Fresenius Kabi
- Slovakia · Capecitabine Pharmacenter, Capecitabine Pharmagen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ba9e4bac-6364-4854-b08b-944a3ab69f55 GET /v1/drugs/ba9e4bac-6364-4854-b08b-944a3ab69f55?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "24376511000001109",
"desc": "Capecitabine 300mg tablets (medac UK)",
"form": "Oral tablet",
"vpid": "24407611000001109",
"source": "dmd",
"vtm_id": "775034000",
"strength": "300 mg",
"substance": "Capecitabine",
"ingredient": "Capecitabine",
"supplier_code": "9241811000001108"
}See everything about capecitabine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.